$MLYS
Mineralys Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Radnor, PA
MLYS chart
What traders are saying about $MLYS
Latest postsMineralys Therapeutics, Inc. news
- Mineralys Therapeutics will report financial results after stock ends session up 1.1%
Traders Union ·
- Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
Yahoo Finance ·
- Mineralys Therapeutics to Announce Third Quarter 2026
GlobeNewswire ·
- Mineralys Drug Cuts Kidney Damage Marker 52% in Trial
MyChesCo ·
- Mineralys Therapeutics announces full results from Explore-CKD trial
TipRanks ·
- Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International
Yahoo Finance ·
- Mineralys Therapeutics Announces Publication of Phase 2
GlobeNewswire ·
- Mineralys Adds Pharma Veterans Ahead of Potential Drug Launch
MyChesCo ·
- Mineralys Therapeutics director Slingsby sells $3.0 million in shares By Investing.com
Investing.com Australia ·
- Form 4 Mineralys Therapeutics Inc: Brian Taylor Slingsby (Director) For: 22 September
Investing.com Canada ·
- Phase 3 Kidney Data Might Change The Case For Investing In Mineralys Therapeutics (MLYS)
Simply Wall Street ·
- Mineralys Therapeutics (MLYS) Slides 4.29% to $20.55, Testing the Middle of Its Recent Range - Insider Buying Alerts
www.dars.gov.et ·
Mineralys Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$154.7M | -$177.8M | -$71.9M | -$29.8M |
| Diluted EPS | $-2.29 | $-3.66 | $-1.99 | $-5.77 |
| Total assets (year end) | $661.8M | $205.9M | $251.6M | $114.4M |
| Cash and equivalents (year end) | $172.9M | $114.1M | $49.3M | $87.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Mineralys Therapeutics, Inc.
- Ticker
- MLYS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Radnor, PA
- Fiscal year end
- December 31
- SEC CIK
- 1933414
Frequently asked questions
What exchange is Mineralys Therapeutics, Inc. listed on?
Mineralys Therapeutics, Inc. trades on the Nasdaq under the ticker symbol MLYS.
What industry is Mineralys Therapeutics, Inc. in?
Mineralys Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Mineralys Therapeutics, Inc. headquartered?
Mineralys Therapeutics, Inc.'s business address on file with the SEC is in Radnor, PA.
When does Mineralys Therapeutics, Inc.'s fiscal year end?
Mineralys Therapeutics, Inc.'s fiscal year ends on December 31.